Related Experiment Videos
A case of toxic epidermal necrolysis secondary to indomethacin
British Journal of Rheumatology
|February 1, 1983
Abstract:
A middle-aged female with rheumatoid arthritis was commenced on indomethacin. Four days later she developed the classical clinical and histological features of toxic epidermal necrolysis (TEN). The association with indomethacin has not previously been reported.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Diagnostic Accuracy of the Faecal Immunochemical Test in Triage of Symptomatic Patients Referred for Colonoscopy: A Prospective Single-Centre Study.
Canadian journal of gastroenterology & hepatology·2025
Spinal anesthesia for cesarean delivery resulting in postdural puncture headache and intracranial subdural hematoma: a case report.
International journal of obstetric anesthesia·2025
Surgical procedure prediction using medical ontological information.
Computer methods and programs in biomedicine·2023
National Audit of Criteria For Pre-Operative Sickle Cell Screening in Children.
Irish medical journal·2022
Hypothyroid myopathy as a complication of interferon alpha therapy for chronic hepatitis C virus infection.
British journal of rheumatology·1999
Benefit of 6 months long-term physical training in polymyositis/dermatomyositis patients.
British journal of rheumatology·1999
Circulating interleukin-16 in systemic lupus erythematosus.
British journal of rheumatology·1999
Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis.
British journal of rheumatology·1999
Clinical course and remission rate in patients with early rheumatoid arthritis: relationship to outcome after 5 years.
British journal of rheumatology·1999
A study of the frequency of pericardial and pleural effusions in scleroderma.
British journal of rheumatology·1999
Comparing the efficacy of first-line immunotherapies in autoimmune encephalitis: a scoping review.
Frontiers in neurology·2026
Cryo-EM reveals patient- versus organ-specific structural diversity and bound ligands in λ6 light chain amyloids.
bioRxiv : the preprint server for biology·2026